Facebook Linkedin Twitter
Inside Precision Medicine How Much Have We Impacted Cancer Deaths, and Through What?  

Cancer vaccine

Human papilloma virus, illustration
News & Features

How Much Have We Impacted Cancer Deaths, and Through What?  

0
Pancreatic cancer
News & Features

Drug Combination Boosts Immune Response in Resistant Pancreatic Cancers

0
E. coli bacteria
News & Features

Engineered Probiotic Bacteria Show Potential as Personalized Cancer Vaccines

0
Medical vaccine
News & Features

Comprehensive AI-Enabled Pipeline Aids Development of Personalized Cancer Vaccines

0
Three strands of DNA
News & Features

Expanding the Focus of Precision Medicine from Treatment to Prevention

Surya Singh, MD
0
Lung Cancer
News & Features

Global Trial of BioNTech’s mRNA-Based Lung Cancer Vaccine Launches

0
3D image illustrating immune cells attacking cancer cells in immunotherapy such as that used in cancers with mismatch repair deficiency
News & Features

BioNTech’s mRNA Vaccine Combo Scores in Phase II

0
Immune checkpoint inhibitors: Interaction between PD-1 and PD-L1 blocked by therapeutic antibodies
News & Features

Boehringer Acquires Nerio with Its Novel Checkpoint Inhibitors for $1.3B

0
3d render of CAR T cells attacking and killing blood cancer cells
News & Features

Early T-Cell Activation and Anti-Cancer Potential: A Goldilocks Effect

0
Oncologist Discussing Medications with a Senior Patient
News & Features

NHS Launches Nationwide Personalized Cancer Vaccine Trial Program

0
123Page 1 of 3

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine